{"id":211559,"name":"JOHNSON & JOHNSON SERVICES, INC.","slug":"johnson-johnson-services-inc","state":"DC","country":"United States of America","description":"Global biopharmaceutical, medical device and consumer product manufacturer.","totalSpending":1000000,"filings":21,"yearlySpending":[{"year":2021,"income":100000},{"year":2022,"income":250000},{"year":2023,"income":200000},{"year":2024,"income":250000},{"year":2025,"income":200000}],"issues":[{"code":"BUD","display":"Budget/Appropriations"},{"code":"HCR","display":"Health Issues"},{"code":"MMM","display":"Medicare/Medicaid"},{"code":"LAW","display":"Law Enforcement/Crime/Criminal Justice"}],"firms":["SPLITOAK STRATEGIES LLC"],"lobbyists":["AMY JENSEN","SARAH EGGE","KRISTEN SHATYNSKI"],"govEntities":["SENATE","HOUSE OF REPRESENTATIVES","Drug Enforcement Administration (DEA)"],"sampleDescriptions":["General health care issues in federal health programs; general federal budget and appropriations issues related to health care policy; general health care and public health issues","General health care issues in federal health programs; general federal budget and appropriations issues related to health care policy; general health care and public health issues","General health care issues in federal health programs; general federal budget and appropriations issues related to health care policy; general health care and public health issues","S. 2706, DIVERSE Trials Act; COVID-19 vaccinations","Value of prescription drugs\nIssues related to Medicare Parts B & D"]}